"For us, the number of Cialis prescriptions written by urologists is one of the most important indicators of future trends. Urologists are the experts in treating ED.
Cialis® (tadalafil) marks 10 years since U.S. approval
27, 2018. Lilly reached the settlement with generic drugmakers over a dispute on a unit dose patent set to expire in 2020. After its initial approval in 2003, Cialis’ exclusivity had been expected to end in November, just a month before Pfizer’s rival med Viagra. With the new agreement, Lilly can work to squeeze more branded sales out of a med that’s been an important contributor over the years. Last year, the drug turned in $1.469 billion in U.S.
Why Should I Pay More For the Same Results?
sales, or 7% of the drugmaker’s global haul. RELATED: Top 10 U.S. patent losses of 2017 - Cialis In a statement, Lilly’s general counsel Michael Harrington said the “unit dose patent for Cialis is valid and infringed by companies seeking to market a generic version of Cialis.” He added the deal includes a “royalty-bearing license agreement that provides us with more certainty regarding our U.S. exclusivity.” Generics from Aurobindo, Teva Pharmaceutical, Alembic, Watson, Sun Pharma and Synthon are tentatively FDA-approved and ready to roll, according to Drugs@FDA. RELATED: Are Viagra and Cialis leaving TV advertising?
Innovation and Next-Generation Therapies
Report forecasts end of ED era on NFL football 2 in FiercePharma’s report in May detailing the top patent losses of 2017. At the time, analysts with life science commercial intelligence firm EvaluatePharma predicted the med would lose 96% of its sales by 2022, tumbling to $55 million that year as a host of cheap generics flood the market. Over the years, Lilly has grown its key ED brand with a great deal cialis street price of advertising, building an identity around couples in bathtubs in TV ads and elsewhere. But as it nears the end of its patent life, Lilly will likely pull back on advertising. A recent report from Advertising Age said the company and Pfizer are pulling their NFL ad campaigns. We expected that urologists would be the quickest adopters of Cialis, and the data suggest
| Product | Dosage | Quantity + Bonus | Price | |
|---|---|---|---|---|
| Cialis Generic | 10mg | 270 + 10 Pills | 308.71€ 294.01€ | |
| Cialis Generic | 2.5mg | 10 Pills | 28.51€ 27.15€ | |
| Cialis Generic | 10mg | 30 + 4 Pills | 63.32€ 60.30€ | |
| Cialis Generic | 60mg | 10 Pills | 41.22€ 39.26€ | |
| Cialis Generic | 10mg | 360 + 10 Pills | 388.49€ 369.99€ | |
| Cialis Soft Tabs | 20mg | 60 + 4 Pills | 159.37€ 151.78€ | |
| Cialis Generic | 5mg | 180 + 10 Pills | 159.65€ 152.05€ | |
| Cialis Generic | 60mg | 60 + 4 Pills | 145.06€ 138.15€ | |
| Cialis Generic | 5mg | 120 + 6 Pills | 132.92€ 126.59€ | |
| Cialis Generic | 2.5mg | 30 + 4 Pills | 51.95€ 49.48€ | |
| Cialis Super Active | 20mg | 270 + 30 Pills | 661.49€ 629.99€ | |
| Cialis Soft Tabs | 20mg | 20 + 2 Pills | 66.98€ 63.79€ | |
| Cialis Generic | 10mg | 60 + 6 Pills | 105.81€ 100.77€ | |
| Cialis Generic | 2.5mg | 360 + 10 Pills | 260.03€ 247.65€ | |
| Cialis Black | 80mg | 120 + 8 Pills | 264.77€ 252.16€ |
that these specialists, like their peers overseas, are making Cialis their preferred treatment," said Blum.
Overall Customer Reviews
Picture of authentic bottle of Eli Lilly’s Cialis 20 mg Tablets sold in the U.S. This release was issued by Lilly ICOS LLC Cialis Leads Market in New Treatment Initiations and Switches for April After only six months, Cialis® (tadalafil)1, the latest oral erectile dysfunction (ED) treatment on the market in the U.S., is challenging Viagra® (sildenafil citrate)2for share of the ED market as Cialis leads in new treatment initiations by urologists3 and switches from other products for April. Cialis is marketed by Lilly ICOS LLC, a joint venture between Eli Lilly and Company (NYSE: LLY) and ICOS Corporation (Nasdaq: ICOS). Cialis is the only ED treatment shown to improve erectile function up to 36 hours in most men. Cialis can be taken without regard to food.
Regulatory Approvals
According to market research firm ImpactRx™ (which tracks the habits of a panel of high prescribing physicians and may reflect emerging trends in doctors’ offices today)4, U.S. urologists initiated treatment with Cialis in April at a rate of more than two-to-one over each of the other oral ED treatments. In fact, Cialis represented 56 percent of new treatment initiations by urologists in April, compared to 21 percent for Levitra (vardenafil HCl)5 and 23 percent for Viagra.6 Based on data from IMS, another source of market information, in April, Cialis represented 30 percent of new ED treatment prescriptions written by urologists, compared to 16 percent for Levitra and 54 percent for Viagra.7 In April, nearly two thirds of all men who switched their oral ED treatment switched to Cialis. Following is information from ImpactRx™ on share of is cialis generic new prescriptions written in April by doctors changing their patients' ED treatment from product to another. In an independent clinical study, more men selected Cialis as their preferred treatment of choice after trying different oral ED medications, primarily because of how long the drug worked.8 This may explain why many men with ED who are on oral treatment are switching to Cialis. Cialis is changing the way doctors and patients think about treating ED
| Formulation | Dosage Range | Appearance | Typical Use | Packaging Options |
|---|---|---|---|---|
| Tablet | 2.5 mg, 5 mg, 10 mg, 20 mg | Blue, oval | ED, BPH | Blister packs |
| Orally Dispersible | 10 mg | Peach-colored | ED | Blister packs |
| Special Formulations | Daily use tablet | White, round | Regular use | Blister, bottle |
by offering two important benefits: a 36-hour window of opportunity for intimacy and
- When traveling, patients should carry Cialis Lilly in original packaging with prescription.
- Cialis Lilly is effective in men with various causes of erectile dysfunction including diabetes.
- It is less prone to food-related interference compared to some other ED drugs.
- The brand constantly updates safety information based on new clinical findings.
- Discontinuation should be discussed with healthcare provider; sudden stop rarely causes issues.
- Cialis Lilly can improve symptoms of BPH by relaxing bladder and prostate muscles.
- Combining Cialis Lilly with recreational drugs can be dangerous and is strongly discouraged.
- Patient education materials cover steps to maximize benefit and minimize risks.
- Eli Lilly provides worldwide customer service to answer product inquiries professionally.
- Cialis Lilly remains a trusted and effective choice for men’s sexual health needs.
the ability to take the tablet on an empty stomach or with a
- Ongoing research may explore new formulations or delivery methods.
- Studies on its potential effects in other conditions (e.g., Raynaud's) exist.
- Investigation into cardiovascular benefits remains a topic of interest.
- The role of daily tadalafil in early-stage Peyronie's disease is studied.
- Post-generic, Lilly's focus shifted to newer therapeutic areas.
- Real-world data collection continues to inform long-term use patterns.
- Patient adherence and persistence with therapy are research subjects.
- The legacy of Cialis as a blockbuster drug influences pharmaceutical R&D.
meal, without concern that high-fat food will reduce the absorption of the medicine.
- Cialis Lilly’s tadalafil is distinct for its longer half-life compared to sildenafil (Viagra).
- Patients report improvements in sexual performance and confidence.
- It also helps relieve symptoms of enlarged prostate, such as frequent urination.
- Cialis Lilly requires a prescription from a healthcare professional.
- Possible side effects include headache, indigestion, back pain, and muscle aches.
- It should not be combined with nitrates due to risk of severe hypotension.
- Cialis Lilly does not protect against sexually transmitted infections.
- The medication may interact with alpha-blockers, requiring caution.
- It should be stored at room temperature away from moisture and heat.
- Cialis Lilly is not recommended for use by women or children.
"What the marketplace tells us is that men and their partners are truly taking advantage of the benefits of Cialis," said Matt Beebe, U.S.
Lilly ICOS' Cialis (tadalafil) Makes Impressive Strides in First Six Months on the U.S. ED Treatment Market
Therefore, these products are considered unsafe and should not be used. FDA also recommends consumers talk to their health care professional about their condition and options for treatment if they received a counterfeit product. FDA-approved Cialis tablets made by Eli Lilly contain the active ingredient, tadalafil, and are used for the treatment of erectile dysfunction and other approved indications. Currently, Eli Lilly’s authentic product is considered safe and effective for its intended uses. There is no indication that the legitimate supply chain is at risk, therefore consumers can be confident that prescription medicines received through legitimate state-licensed pharmacies located in the U.S.
Revenue Projections for 2023-2025
are safe and effective. Counterfeit versions of Cialis can be identified by the following differences on the label of the bottle when compared to the authentic product. lists “AUSTR81137” on the front of the bottle; does not include an NDC number on the front of the bottle, such as “NDC 0002-4462-30” for the 20 mg tablets; does not include the tablet strength in a colored box; has different patterns cialis pills 20 mg and colors; it has yellow and darker green designs on the front label; has misspellings; it lists, “CLALIS is a product of: Eli lilly Australia PTY Limited” on the side of the bottle; lists the manufacturer location as “112 Wharf Road, WEST RYDE, NSW 2114” on the side of the bottle; and lists “Lot: AC 066018, Exp: 01SEP17” on the side of the bottle. Consumers should not use products that match one or more of the descriptions above. If you have additional information about these products, you may contact FDA at DrugSupplyChainIntegrity@fda.hhs.gov.
Pulmonary arterial hypertension
To date, FDA is not aware of consumer adverse events related to the use of these counterfeit versions of Cialis. Health care professionals and consumers are encouraged to report adverse events related to the use of any suspect medications to FDA’s MedWatch Adverse Event Reporting program by: Completing and submitting the report online at MedWatch Online Voluntary Reporting Form Downloading and completing the form (PDF - 1.22MB), then submitting it via fax at 1-800-FDA-0178 Consumers who buy prescription medicines online should be careful. Some websites sell medicine that may not be safe to use and may put their health at risk. Go to for more information about the risks, to learn the signs of websites that may sell counterfeit or otherwise unsafe medicines, and how to find legitimate licensed online pharmacies. FDA is committed to protecting public health by working to secure the drug supply chain against counterfeit and unapproved medications that enter the United States through fraudulent sources. brand team leader for Cialis, Lilly ICOS LLC.
Key Takeaways: Cialis vs Tadalafil
The percentages of new prescriptions written by all doctors for oral ED treatments in April broke out as follows: Cialis, 19 percent; Levitra, 14 percent; and Viagra, 67 percent.9 "The early success of Cialis in the U.S. is similar to the trend we saw when it first became available in other countries. Cialis has claimed market shares of 19 percent to 39 percent across Europe, and even higher in some other markets," said Leonard Blum, vice president of marketing, ICOS Corporation. In the first quarter of 2004, Cialis achieved $108 million in global sales. More than two million men around the world have been treated with Cialis since its first introduction globally last year. "Men can take Cialis Friday evening and choose the moment for romance as late as Sunday morning.
| Topic | Key Points | Resources |
|---|---|---|
| Proper Dosage | Take as prescribed; do not exceed 20 mg per dose | Physician consultation |
| Timing with Food | Can be taken with or without food; delays absorption if high-fat meal | Patient leaflet |
| Alcohol Interaction | Avoid excessive alcohol as it may impair effectiveness | Medical advice |
| Recognizing Side Effects | Seek medical help if experiencing prolonged erections (>4 hours) | CDC guidelines |
Because Cialis works for up to 36 hours, it allows a man and his partner to
Product Description
How should Eli Lilly further develop and market a new indication of its highly successful erectile-dysfunction (ED) drug, Cialis, without confusing Cialis's hard-won brand equity with physicians and patients? With the final stages of clinical trials for the new indication, benign prostatic hyperplasia (BPH), soon to be carried out, the team had to make a decision soon. On its face, the market opportunity for a BPH indication, and its synergies with an ED drug, seemed enormous: both ED and BPH were age-related conditions, and data showed that half of men with ED had BPH symptoms. Moreover, the BPH indication would be taken in the same frequency and dosing as the once-a-day version of Cialis. However, market research had revealed significant challenges in introducing the BPH indication under the Cialis name.
More FAQ
For example, although ED and BPH often co-existed, men perceived them quite differently. Some physicians also reacted negatively to the BPH indication. Impending competition from low-price ED generics, given that Viagra would soon be going off patent, underscored the importance of the BPH opportunity. FDA is alerting consumers and health care professionals that counterfeit versions of Cialis 20 mg tablets were found in the mail on its way to a U.S. consumer.
Manufacturers’ Strategies
While this shipment was stopped, FDA is concerned about other possible mail shipments to consumers. FDA laboratory analysis showed the counterfeit versions contain multiple active ingredients, which if used could result in adverse effects or harm. Consumers should only buy prescription medicines from state-licensed pharmacies located in the U.S. FDA cannot confirm that the manufacturing, quality, storage, and handling of these products follow U.S. standards because these products are from an unknown source. relax, forget about planning intimacy and let it happen when the moment is right for them."
| Development Area | Innovation Focus | Expected Benefits | Timeline |
|---|---|---|---|
| New Formulations | Long-acting or dissolvable tablets | Increased patient convenience | 2025-2027 |
| Combination Drugs | Cialis + other ED meds | Improved efficacy and options | 2024-2026 |
| Digital Health Integration | Apps for dosage reminders | Better adherence, monitoring | 2024 onward |
| Personalized Medicine | Tailored dosing based on genetics | Enhanced safety and effectiveness | 2025-2028 |